Silver Spring’s United Therapeutics betting big on organ manufacturing despite death of pig heart recipient


The company's CEO calls it "a long-term plan to address one of the largest critical unmet medical needs."

Previous Former Reata Pharmaceuticals CFO steps into new role with California biotech company
Next Wake Forest University School of Medicine launches $100 million campaign to fund research